Mi SciELO
Servicios Personalizados
Revista
Articulo
Indicadores
Citado por SciELO
Accesos
Links relacionados
Citado por Google
Similares en SciELO
Similares en Google
Compartir
Archivos de la Sociedad Española de Oftalmología
versión impresa ISSN 0365-6691
Resumen
RAMOS-LOPEZ, JF et al. Treatment of conjunctival intraepithelial neoplasia with topical mitomycin C 0.02%. Arch Soc Esp Oftalmol [online]. 2004, vol.79, n.8, pp.375-378. ISSN 0365-6691.
Purpose: To evaluate the efficacy of topical mitomycin C (MMC) 0.02% in treating conjunctival intraepithelial neoplasia (CIN). Methods: Three patients with CIN were treated with topical MMC 0.02%. Our follow-up period was twelve months (range 8-18 months). Results: CIN was resolved in all three cases without modifying the normal corneal and conjunctival architecture. Conclusions: Topical MMC 0.02% four times daily during two weeks is a useful alternative tool for the surgical management of CIN.
Palabras clave : Mitomycin C; conjunctival intraepithelial neoplasia.